# Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer

> **NCT00068744** · PHASE2,PHASE3 · TERMINATED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 88 (actual)

## Conditions studied

- Anal Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **DRUG:** mitomycin C
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00068744
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** 2007-11
- **Final completion:** —
- **Target enrollment:** 88 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2012-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00068744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00068744, "Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00068744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*